Form D · Biotechnology
RenBio, Inc.
Long Island City, NY · CIK 0001840723
Offering snapshot reported Sep 6, 2024 · SEC filing
- Reported sold
- $5.25M Offering amount: $6M
- Investors reported
- 7 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Aug 22, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 6, 2024 | Initial | $5,250,000 | No comparison | 7 | SEC filing |
| Jan 19, 2021 | Initial | $14,000,000 | No comparison | 7 | SEC filing |
Offering details
- Securities
- Debt, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-523398
Source: Form D, filed Sep 6, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Chi Chuan Chen | Director |
| David Chu | Director |
| Jaap Goudsmit, M.D., Ph.D. | Director |
| Zhi Hong, Ph.D. | Director |
| Rachel A. Liberatore, Ph.D. | Director, Executive |
| Annelyn O'rourke | Executive |
| Neal Padte | Director, Executive |
| Donald Tang | Director |
| Wan Feng Ting | Director |
| Tamon Tseng | Director |
| Walter Wang, Sr. | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
30 02 48th Avenue
Long Island City, NY, 11101
Long Island City, NY, 11101